The store will not work correctly when cookies are disabled.
4-(1-(quinuclidin-3-yl)-1H-1,2,3-triazol-4-yl)phenol
ID: ALA4472617
PubChem CID: 122553341
Max Phase: Preclinical
Molecular Formula: C15H18N4O
Molecular Weight: 270.34
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Oc1ccc(-c2cn(C3CN4CCC3CC4)nn2)cc1
Standard InChI: InChI=1S/C15H18N4O/c20-13-3-1-11(2-4-13)14-9-19(17-16-14)15-10-18-7-5-12(15)6-8-18/h1-4,9,12,15,20H,5-8,10H2
Standard InChI Key: ZRCMYKLGYHVJGO-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 23 0 0 0 0 0 0 0 0999 V2000
5.7615 -23.4340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4874 -23.0994 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.9127 -22.6954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3016 -23.4488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3518 -22.0930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6256 -22.3736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4084 -22.7127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5924 -21.5054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1217 -22.3161 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.8633 -22.6594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4190 -22.0601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0208 -21.3465 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.2191 -21.5047 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.2362 -22.0635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6395 -22.7726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4560 -22.7764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8684 -22.0699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4584 -21.3581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6433 -21.3578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6856 -22.0723 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 1 0
2 4 1 0
2 5 1 0
3 6 1 0
4 7 1 0
5 8 1 0
6 7 1 0
6 8 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 9 1 0
7 9 1 0
11 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
17 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 270.34 | Molecular Weight (Monoisotopic): 270.1481 | AlogP: 1.92 | #Rotatable Bonds: 2 |
Polar Surface Area: 54.18 | Molecular Species: BASE | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.54 | CX Basic pKa: 8.93 | CX LogP: 1.57 | CX LogD: 0.37 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.91 | Np Likeness Score: -0.61 |
References
1. Sarasamkan J, Scheunemann M, Apaijai N, Palee S, Parichatikanond W, Arunrungvichian K, Fischer S, Chattipakorn S, Deuther-Conrad W, Schüürmann G, Brust P, Vajragupta O.. (2016) Varying Chirality Across Nicotinic Acetylcholine Receptor Subtypes: Selective Binding of Quinuclidine Triazole Compounds., 7 (10): [PMID:27774124] [10.1021/acsmedchemlett.6b00146] |